Quarterly report pursuant to Section 13 or 15(d)

Warrants

v3.7.0.1
Warrants
3 Months Ended
Mar. 31, 2017
Warrants [Abstract]  
Warrants

12. Warrants

As of March 31, 2017, warrants to purchase 46,067,547 shares were outstanding, having exercise prices ranging from $0.30 to $1.28 and expiration dates ranging from December 4, 2017 to March 19, 2022.  





 

 

 

 

 

 



 

 

 

 

 

 



2017

2016



Number of warrants

Weighted average exercise price

Number of warrants

Weighted average exercise price

Balance, January 1

54,526,847 

$

0.49  26,491,904 

$

0.80 

Issued during the period

 -

$

 -

12,500,000 

$

0.42 

Exercised during the period

(8,459,300)

$

0.34 

 -

$

 -

Expired during the period

 -

$

 -

 -

$

 -



 

 

 

 

 

 

Balance, March 31

46,067,547 

$

0.52  38,991,904 

$

0.68 

At March 31, 2017 the weighted average remaining contractual life of the outstanding warrants was 3.9 years.



The warrants issued to investors in the December 2012, November 2015, March 2016, September 2016, and previous offerings contain a provision for net cash settlement in the event that there is a fundamental transaction (contractually defined as a merger, sale of substantially all assets, tender offer or share exchange).  If a fundamental transaction occurs in which the consideration issued consists principally of cash or stock in a non-public company, then the warrant holder has the option to receive cash, equal to the fair value of the remaining unexercised portion of the warrant.  Due to this contingent redemption provision, the warrants require liability classification in accordance with ASC 480 and are recorded at fair value.  The warrants issued to investors in the July 2013, October 2013 and January 2014 offerings contain a fundamental transaction provision, but the warrant holders only have an option as to the type of consideration received if the holders of common stock receive an option as to their consideration.  In addition, the warrants issued in the December 2012, July 2013, October 2013, January 2014, November 2015, March 2016, September 2016 and previous offerings contain a cashless exercise provision that is exercisable only in the event that a registration statement is not effective. That provision may not be operative if an effective registration statement is not available because an exemption under the U.S. securities laws may not be available to issue unregistered shares.  As a result, net cash settlement may be required, and the warrants require liability classification.



ASC 820 provides requirements for disclosure of liabilities that are measured at fair value on a recurring basis in periods subsequent to the initial recognition.  Fair values for warrants were determined using the Binomial Lattice (“Lattice”) valuation technique. The Lattice model provides for dynamic assumptions regarding volatility and risk-free interest rates within the total period to maturity. Accordingly, within the contractual term, the Company provided multiple date intervals over which multiple volatilities and risk free interest rates were used. These intervals allow the Lattice model to project outcomes along specific paths that consider volatilities and risk free rates that would be more likely in an early exercise scenario.



Significant assumptions are determined as follows:

Trading market values—Published trading market values;

Exercise price—Stated exercise price;

Term—Remaining contractual term of the warrant;

Volatility—Historical trading volatility for periods consistent with the remaining terms; and

Risk-free rate—Yields on zero coupon government securities with remaining terms consistent with the remaining terms of the warrants.



Due to the fundamental transaction provision, which could provide for early redemption of the warrants, the model also considered the probability the Company would enter into a fundamental transaction during the remaining term of the warrant. Because the Company is not yet achieving positive cash flow, management believes the probability of a fundamental transaction occurring over the term of the warrant is unlikely and therefore estimates the probability of entering into a fundamental transaction to be 5%.  For valuation purposes, the Company also assumed that if such a transaction did occur, it was more likely to occur towards the end of the term of the warrants.



The significant unobservable inputs used in the fair value measurement of the warrants include management’s estimate of the probability that a fundamental transaction may occur in the future.  Significant increases (decreases) in the probability of occurrence would result in a significantly higher (lower) fair value measurement.

The following table summarizes the fair value of the warrants as of the respective balance sheet dates:





 

 

 

 

 



 

 

 

 

 



 

Fair Value as of:

Warrant Issuance:

 

March 31, 2017

December 31, 2016

December 2012 Investor Warrants

 

$

42,770 

$

49 

July 2013 Investor Warrants

 

 

551,440 

 

2,060 

October 2013 Investor Warrants

 

 

680,918 

 

3,708 

January 2014 Investor Warrants

 

 

1,082,524 

 

714 

November 2015 Investor Warrants

 

 

4,380,250 

 

260,500 

November 2015 Placement Agent Warrants 

 

 

285,367 

 

13,542 

March 2016 Investor Warrants

 

 

3,491,200 

 

358,945 

March 2016 Placement Agent Warrants

 

 

290,352 

 

21,320 

September 2016 Investor Warrants

 

 

5,429,010 

 

854,640 

September 2016 Placement Agent Warrants

 

 

 -

 

57,888 

Total:

 

$

16,233,831 

$

1,573,366 

The following table summarizes the number of shares indexed to the warrants as of the respective balance sheet dates:





 

 

 



 

 

 



 

Number of Shares indexed as of:

Warrant Issuance

 

March 31, 2017

December 31, 2016

December 2012 Investor Warrants

 

174,300  174,300 

July 2013 Investor Warrants

 

2,000,000  2,000,000 

October 2013 Investor Warrants

 

2,317,309  2,317,309 

January 2014 Investor Warrants

 

4,761,905  4,761,905 

November 2015 Investor Warrants

 

12,500,000  12,500,000 

November 2015 Placement Agent Warrants 

 

833,333  833,333 

March 2016 Investor Warrants

 

9,299,450  11,718,750 

March 2016 Placement Agent Warrants

 

781,250  781,250 

September 2016 Investor Warrants

 

13,400,000  18,000,000 

September 2016 Placement Agent Warrants

 

 -

1,440,000 

Total:

 

46,067,547  54,526,847 

The assumptions used in calculating the fair values of the warrants are as follows:





 

 

 

 

 

 

 



 

 

 

 

 

 

 



 

March 31, 2017

December 31, 2016

Trading market prices

 

$

0.51 

 

$

0.14 

 

Estimated future volatility

 

 

105 

%

 

104 

%

Dividend

 

 

-

 

 

-

 

Estimated future risk-free rate

 

 

1.08-2.35

%

 

1.06-2.44

%

Equivalent volatility

 

 

94-146 

%

 

51-60 

%

Equivalent risk-free rate

 

 

0.78-1.33

%

 

0.59-1.25

%







Changes in the fair value of the warrant liabilities, carried at fair value, reported as “unrealized (loss) gain on fair value of warrants” in the statement of operations:







 

 

 

 



For the Three Months Ended March 31,



 

2017

 

2016

Expired Warrants

$

 -

$

1,821 

December 2012 Investor Warrants

 

(42,721)

 

1,368 

July 2013 Investor Warrants

 

(549,380)

 

30,654 

October 2013 Investor Warrants

 

(677,210)

 

26,440 

January 2014 Investor Warrants

 

(1,081,810)

 

25,286 

November 2015 Investor Warrants

 

(4,119,750)

 

328,713 

November 2015 Placement Agent Warrants 

 

(271,825)

 

21,882 

March 2016 Investor Warrants

 

(3,932,511)

 

392,145 

March 2016 Placement Agent Warrants

 

(269,032)

 

27,646 

September 2016 Investor Warrants

 

(6,242,191)

 

 -

September 2016 Placement Agent Warrants

 

(503,150)

 

 -

Total:

$

(17,689,580)

$

855,955